Naringenin
bayanin1
bayanin2
Ƙayyadewa
Abubuwan Gwaji | Daidaitacce |
Naringenin (CAS: 67604-48-2) | Kashi 98% ta hanyar HPLC |
Asara idan aka busar da ita | ≤5.0% |
Ragowar wuta | ≤2.0% |

Tushen Halitta

Mai aiki da yawa

Babban Ayyukan Halittu
1. Cibiyar Sadarwar Molecular
2. Magungunan Magunguna
Sha
Bioavailability na baki 15-20% (ƙirƙirar liposomal ta ƙaru zuwa 50%).
Rarrabawa
Yadu sosai a cikin hanta, koda, da kwakwalwa (shigar BBB ~ 5%).
Metabolism
Glucuronidation na hanta (UGT1A1/1A9), hydroxylation (CYP2C9/2C19).
Najasa
Mafi yawan kamuwa da cutar biliary (70%), fitar fitsari ƙasa da 10%.
Aikace-aikacen Asibiti
Nuni | Tsarin aiki | Mataki na Clinical; |
Ciwon suga na Type 2 | Inganta IR + yana hana shan glucose | Gwaje-gwajen Mataki na II |
NAFLD | Metabolism na lipid + tasirin antifibrotic | Gwaje-gwajen Mataki na I |
Ciwon Menopausal | Zaɓaɓɓen ERβ agonism | Kafin a fara aikin asibiti |

Matsalolin Narkewar Abinci

Ƙarin Maganin Kariya daga Cututtuka

Matsakaicin Yawan da Aka Yi Haƙuri da Shi
Kimanta Tsaro
1. Illolin da ke tattare da hakan
Tsarin | Lamarin | Bayyanannu; |
Na ciki | 10% | Gudawa mai sauƙi |
Endocrine | Tasirin Estrogenic | |
Rashin ji sosai | Ba kasafai ake samu ba | Kuraje |
2. Hulɗar Magani
Substrates na CYP3A4 (misali, simvastatin): AUC na iya ninkawa.
Magungunan hana zubar jini (warfarin): Yana tsawaita PT/INR (ana buƙatar sa ido).
Ci gaban Bincike Kore mafi girma
Sabbin Ka'idoji
Nanoemulsions: 80% bioavailability (bayanan dabbobi).
Alamun Transdermal: Don amfani da maganin kumburi na gida (misali, arthritis).
Sabbin Alamomi
COVID-19: Yana hana 3CL protease (IC₅₀=25 μM).
Cutar Parkinson: Yana kunna hanyar Parkin/PINK1 (samfurin ƙwayoyin halitta).
Don Allah a aiko min da imel kuma za ku iya samun ƙarin abin da kuke so.
Kamar samfurin Farashi, Takamaiman Bayani, MOA, MSDS, Jadawalin Gudawa, Cikakkun bayanai game da shiryawa, Lokacin Jigilar Kaya, Lokacin Biyan Kuɗi, sabis bayan Siyarwa da sauransu.
Our experts will solve them in no time.


